US Undiscovered Gems To Watch In May 2026

Over the last 7 days, the United States market has risen by 1.1%, contributing to a remarkable 27% increase over the past year, with earnings expected to grow by 17% annually. In such a dynamic environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering valuable opportunities in the market.

Top 10 Undiscovered Gems With Strong Fundamentals In The United States

Name	Debt To Equity	Revenue Growth	Earnings Growth	Health Rating
First Bancorp	69.86%	1.25%	-3.09%	★★★★★★
New Peoples Bankshares	22.84%	4.06%	9.72%	★★★★★★
Tri-County Financial Group	54.21%	-0.70%	-10.52%	★★★★★★
Cashmere Valley Bank	31.63%	5.07%	1.43%	★★★★★★
ASA Gold and Precious Metals	NA	12.65%	41.20%	★★★★★★
Anbio Biotechnology	NA	-30.09%	-3.45%	★★★★★★
First Northern Community Bancorp	NA	7.26%	11.00%	★★★★★★
Affinity Bancshares	41.71%	1.36%	-0.22%	★★★★★★
Winchester Bancorp	123.28%	9.14%	-54.82%	★★★★★★
Union Bankshares	406.25%	1.42%	-7.24%	★★★★☆☆

Click here to see the full list of 339 stocks from our US Undiscovered Gems With Strong Fundamentals screener.

Let's dive into some prime choices out of from the screener.

NVE (NVEC)

Simply Wall St Value Rating: ★★★★★★

Overview: NVE Corporation specializes in developing and selling spintronics-based devices for information acquisition, storage, and transmission, with a market cap of approximately $462.43 million.

Operations: The company generates revenue primarily from its electronic components and parts segment, which amounts to $26.33 million.

NVE, a debt-free player in the semiconductor industry, boasts a price-to-earnings ratio of 29.5x, significantly below the industry average of 63.4x. Over the past five years, its earnings have seen modest growth at 0.9% annually, though this trails behind the industry's pace of 12.3%. The company has consistently delivered high-quality earnings and reported net income of US$15.2 million for the year ending March 2026, slightly up from US$15.06 million previously. With Semitech now distributing its isolation products across various sectors, NVE is poised to enhance market presence and product adoption in critical applications like medical and automotive industries.

• Get an in-depth perspective on NVE's performance by reading our health report here.

• Explore historical data to track NVE's performance over time in our Past section.

Electromed (ELMD)

Simply Wall St Value Rating: ★★★★★★

Overview: Electromed, Inc. is a company that specializes in the development, manufacturing, marketing, and sale of airway clearance therapy products using high frequency chest wall oscillation (HFCWO) technology for pulmonary care, with a market cap of $281.77 million.

Operations: Electromed generates revenue primarily from developing, manufacturing, and marketing medical equipment, amounting to $71.75 million. The company's financial performance includes a focus on managing costs associated with these operations to optimize profitability.

Electromed, a player in the medical equipment sector, is capitalizing on increased awareness of bronchiectasis and home care solutions. The company reported a significant earnings growth of 41.1% over the past year, outpacing the industry average of 14%. With no debt to worry about and high-quality earnings, Electromed's financial health seems robust. Recent results show sales for Q3 at US$18.58 million compared to US$15.68 million last year, with net income rising from US$1.89 million to US$3 million. Despite these positives, reliance on the U.S market and SmartVest platform poses risks due to potential policy changes or competitive pressures.

• Electromed's growth is driven by increased awareness and strategic investments despite U.S. market reliance. Click here to explore the full narrative on Electromed's investment thesis.

HCI Group (HCI)

Simply Wall St Value Rating: ★★★★★★

Overview: HCI Group, Inc. operates in the property and casualty insurance sector in the United States, with a market capitalization of approximately $1.96 billion.

Operations: HCI Group generates revenue primarily from its insurance operations, which contribute $841.76 million, and its Exzeo segment, which adds $226.52 million. The company also earns from reciprocal exchange operations totaling $81.26 million and real estate activities at $16.18 million. Net profit margin trends can provide insights into the company's financial efficiency over time.

HCI Group stands out with its strategic focus on technology and underwriting, leading to a 130.5% earnings growth over the past year, outpacing the insurance industry average of 36.8%. With a debt-to-equity ratio dropping from 52.9% to 5.7% in five years, HCI's financial health appears robust. However, challenges loom with anticipated profit margin declines from 31.9% to 18.4%, influenced by rising reinsurance costs and dependency on Florida's market dynamics for policy growth. The company has initiated an $80 million share repurchase program, highlighting confidence in its valuation despite these hurdles and future uncertainties in revenue streams and market conditions.

• HCI Group's focus on proprietary technology and disciplined underwriting drives profitability. Click here to explore how these strategies position HCI as a tech-forward insurer with promising prospects.

Next Steps

• Click here to access our complete index of 339 US Undiscovered Gems With Strong Fundamentals.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com